InvestorsHub Logo

James salmon

01/23/17 10:04 PM

#11703 RE: ignatiusrielly35 #11702

No idea but good to see.

Just maybe those trial results are looking better each day, and more hospitals wanting to get on board.

oakrock

01/23/17 10:33 PM

#11707 RE: ignatiusrielly35 #11702

So you think AstraZeneca is the suitor because most further along with AXALIMOGENE FILOLISBAC?

http://www.advaxis.com/wp-content/uploads/2017/01/Advaxis-Clinical-Pipeline.pdf